Product Description
Basic Characters
| Name: | Cannabidiol powder |
| CAS: | 13956-29-1 |
| Molecular Formula: | C21H30O2 |
| Molecular Weight: | 314.46 g/mol |
| Melt Point: | 77°C |
| Color: | White powder |
| Storage Temp: | Store at 15°C-25°C, protect from moisture and light |
What is Cannabidiphorol powder?
Cannabidiol (CBDP) powder is a cannabinoid discovered in certain strains of the cannabis plant.[3][5][6]It belongs to the same class of compounds as the well-known cannabinoids CBD (cannabidiol) and THC (tetrahydrocannabinol). CBDP is similar in molecular structure to the cannabis compounds THC and CBD, but is 30 times more potent.[2][3][7]Although relatively little research has been done on CBDP, early research suggests it may have similar therapeutic properties to CBD, including potential benefits for anxiety, depression, pain relief, and inflammation.
The research on Cannabidiphorol (CBDP)
A group of Italian scientists spearheaded the ground-breaking study on Cannabidiphorol (CBDP), and their results were published in a paper titled “A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than 9-tetrahydrocannabinol: 9-Tetrahydrocannabiphorol” in the prestigious journal Scientific Reports in late December 2019. This study represented a crucial turning point because it offered the first comprehensive investigation of CBDP.
The structural characterization of CBDP and its possible interactions with cannabinoid receptors were the main areas of study, with a special focus on the 5-HT1A serotonin receptors, which are known to play a role in mood and anxiety control. Researchers surmised that CBDP and CBD would be similar, suggesting possible therapeutic effects like anti-stress, anti-depressant, and possibly anti-epileptic qualities. This was based on their preliminary findings.
However, it is crucial to note that the early research on CBDP is still in its infancy, and further studies are necessary to fully understand its pharmacological effects, potential therapeutic applications, safety profile, and side effects.
The benefits of Cannabidiphorol powder
According to the research that is currently available, CBDP seems to have similar therapeutic benefits to CBD and may be helpful for illnesses like stress, depression, and anxiety. Additionally, AASraw CBDP has the potential to treat inflammation, discomfort, and epilepsy.
- Alleviating anxiety, stress, and depression
CBDP has the potential to reduce stress, anxiety, and depressive symptoms.[1][3][8][9]CBDP may alter how the brain’s serotonin receptors (5-HT1A) react to naturally occurring serotonin levels by activating these receptors. The “bliss molecule,” serotonin, is essential for controlling anxiety and mood. According to studies, CBD can have considerable anti-stress and anti-depressant benefits through interacting with serotonin receptors.
- Anti-epileptic properties
Recurrent and unprovoked seizures, a hallmark of epilepsy, are brought on by aberrant electrical activity in the brain. Traditional anti-epileptic medicines (AEDs) are frequently used to manage seizures, but some people may find that they are ineffective and experience negative effects.
CBDP is thought to interact with the 5-HT1A receptor, which is essential for controlling the release of neurotransmitters like serotonin in the brain. Serotonin plays a role in regulating mood, anxiety, and seizure activity, among other physiological processes.
Some preliminary research suggests that cannabinoids, such as CBD and maybe CBDP, may control neurotransmitter release and affect the excitability of neurons, which may have an impact on seizure activity. Because of its potential to have anti-epileptic effects, CBD in particular has drawn a lot of research.[6][3][8]As a result, a CBD-based medicine (Epidiolex) has been approved to treat specific forms of epilepsy.
Researchers are investigating if CBDP might also have anti-epileptic properties given the structural similarities between CBD and CBDP and their possible interaction with 5-HT1A receptors. Due to this, CBDP may be a valuable addition to the range of therapies available to people with epilepsy, providing viable alternatives for the control of seizures.
- Managing pain and inflammation
Additionally, CBDP might be helpful in reducing inflammation and pain.[1][3] Numerous studies indicate that CBD can successfully treat the symptoms of diseases like fibromyalgia, multiple sclerosis, and arthritis. Given that CBDP and CBD share many similarities, it is logical to infer that their respective effects will be similar.
It is important to note that the research on CBDP is still in its early stages, and further studies are necessary to fully understand its potential benefits and mechanisms of action. Consulting with healthcare professionals and experts in the field is recommended for the most accurate and up-to-date information on CBDP’s effects and uses. Additionally, buying cannabidiphorol (CBDP) powder from a reliable source is crucial. AASraw, as a professional cannabidiphorol (CBDP) powder manufacturer and supplier, can supply pure cannabidiphorol powder under the support of an independent R&D center. It is an excellent choice to buy or wholesale cannabidiphorol powder from AASraw.
Where to buy Cannabidiphorol powder?
Cannabidiphorol (CBDP) powder is a relatively new and under-researched cannabinoid found in certain strains of cannabis.[3][5]Due to its limited availability and recent discovery, CBDP is not as commonly available as more well-known cannabinoids like THC and CBD. Consequently, caution should be exercised when considering the purchase of CBDP products, particularly online.
AASraw are supplying pure Cannabidiphorol powder, which is manufactured under strict quality control standards to ensure purity and potency.[3][4]AASraw provides fast and discreet shipping to customers worldwide, making it easy to get the products you need quickly and conveniently.
How to buy Cannabidiphorol powder from AASraw?
❶To contact us by our email inquiry system, or leave your WhatsApp number to us, our customer service representative(CSR) will contact you in 12 hours.
❷To provide us with your inquired quantity and address.
❸Our CRS will provide you with the quotation, payment term, tracking number, delivery ways, and estimated arrival date(ETA).
❹Payment done and the goods will be sent out in 12 hours.
❺Goods received and give comments.
Author of this article:
Dr. Monique Hong graduated from UK Imperial College London Faculty of Medicine
Scientific Journal paper Author:
1. Alexandra E. Golliher
Department of Chemistry and Biochemistry, New Mexico State University, United States
2. Pasquale Linciano
Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
3. Fred Shahbazi
Department of Chemistry and Biochemistry, University of Windsor, Canada
4. Mohsen Hesami
Gosling Research Institute for Plant Preservation, Department of Plant Agriculture, University of Guelph, Canada
5. Jason Wallach
Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, United States
In no way does this doctor/scientist endorse or advocate the purchase, sale, or use of this product for any reason. Aasraw has no affiliation or relationship, implied or otherwise, with this physician. The purpose of citing this doctor is to acknowledge and commend the exhaustive research and development work done by the scientists working on this substance.
Reference
[1] Gaoni Y, Mechoulam R (1966). “Hashish – VII The isomerization of cannabidiol to tetrahydrocannabinols”. Tetrahedron. 22 (4): 1481–1488.
[2] Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M (January 2018). “Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol”. Neuropsychopharmacology. 43 (1): 142–154.
[3] Citti C, Linciano P, Russo F, Luongo L, Iannotta M, Maione S, et al. (December 2019). “A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol”. Scientific Reports. 9 (1): 20335.
[4] Marks MD, Tian L, Wenger JP, Omburo SN, Soto-Fuentes W, He J, et al. (2009). “Identification of candidate genes affecting Delta9-tetrahydrocannabinol biosynthesis in Cannabis sativa”. Journal of Experimental Botany. 60 (13): 3715–3726.
[5] Adams R, Hunt M, Clark JH (1940). “Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp”. Journal of the American Chemical Society. 62 (1): 196–200.
[6] Silva TB, Balbino CQ, Weiber AF (May 2015). “The relationship between cannabidiol and psychosis: A review”. Annals of Clinical Psychiatry. 27 (2): 134–141.
[7] Bornheim LM, Kim KY, Li J, Perotti BY, Benet LZ (August 1995). “Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain”. Drug Metabolism and Disposition. 23 (8): 825–831.
[8] Verrico CD, Wesson S, Konduri V, Hofferek CJ, Vazquez-Perez J, Blair E, et al. (September 2020). “A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain”. Pain. 161 (9): 2191–2202.
[9] Maa E, Figi P (June 2014). “The case for medical marijuana in epilepsy”. Epilepsia. 55 (6): 783–786.
Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO (August 2007). “Cannabidiol – recent advances”. Chemistry & Biodiversity (Review). 4 (8): 1678–1692.
Get a Bulk quotation
